Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for LianBio Sponsored ADR (LIANY : OTC)

• Company Description    LianBio is a cross-border biotechnology company dedicated to bringing medicines to patients principally in China and other major Asian markets. LianBio is based in SHANGHAI, China. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.05 Daily Weekly Monthly 20 Day Moving Average: 35,485 shares Shares Outstanding: 109.13 (millions) Market Capitalization: $5.67 (millions) Beta: 0.34 52 Week High: $0.18 52 Week Low: $0.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -67.48% -67.72% 12 Week -57.38% -58.54% Year To Date -45.26% -45.53%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 103 CARNEGIE CENTER DRIVE SUITE 309 - PRINCETON,NJ 08540 USA ph: 609-486-2308 fax: - ir@lianbio.com http://www.lianbio.com

• General Corporate Information    Officers Adam Leo Stone - Chief Executive Officer Konstantin Poukalov - Executive Chairman Ehong Gu - Chief Financial Officer Wei Wei Chen - Director Susan Silbermann - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 53000N108 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 109.13 Most Recent Split Date: (:1) Beta: 0.34 Market Capitalization: $5.67 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.28 Price/Cash Flow: 1.16 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 1,466.00 Quick Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 1,466.00 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - 0.19 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - 0.00

Powered by Zacks Investment Research ©